Development of digital PCR-based products to test for cancer related gene mutations in cancer tissue and liquid biopsies

Development of digital PCR-based products to test for cancer related gene mutations in cancer tissue and liquid biopsies

In this dynamic session, presented by Dr. Sung-Hye Hong from Gencurix Inc., we discuss how digital PCR (dPCR) is a key technology in cancer research for cancer-associated mutation detection. Dr. Hong reveals how IDT’s advanced products are driving innovations in dPCR technology, transforming the landscape of cancer mutation detection.

What you’ll learn:

  • Digital PCR overview
  • dPCR-based cancer research tips
  • Strategies for detecting mutations in cancer tissue & liquid biopsy-POLE (tissue), ESR1 (ctDNA), EGFR (tissue/ctDNA)
  • Droplex line-up and multiplex digital PCR approaches

Published on: November 08, 2024

Categories:
qPCR & PCR Webinar